Risk assessment models to estimate cancer probabilities

Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43–66. Barlow WE, White E, Ballard-Barbash R, et al.: Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006, 98:1204–1214. Burgi A, Brodine S, Wegner S, et al.: Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 2005, 104:1505–1511. Chen J, Pee D, Ayyagari R, et al.: Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006, 98:1215–1226. Chen K, Yu WP, Song L, Zhu YM: Quantitative assessment model for gastric cancer screening. World J Gastroenterol 2005, 11:641–644. Cho E, Rosner BA, Feskanich D, Colditz GA: Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 2005, 23:2669–2675. French JL, Wand MP: Generalized additive models for cancer mapping with incomplete covariates. Biostatistics 2004, 5:177–191. Kim DJ, Rockhill B, Colditz GA: Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk. J Clin Epidemiol 2004, 57:332–340. Novotny J, Pecen L, Petruzelka L, et al.: Breast cancer risk assessment in the Czech female population—an adjustment of the original Gail model. Breast Cancer Res Treat 2006, 95:29–35. Rosner BA, Colditz GA, Webb PM, Hankinson SE: Mathematical models of ovarian cancer incidence. Epidemiology 2005, 16:508–515. Simon MS, Korczak JF, Yee CL, et al.: Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women’s Contraceptive and Reproductive Experiences Study. J Clin Oncol 2006, 24:2498–2504. Spitz MR, Hong WK, Amos CI, et al.: A risk model for prediction of lung cancer. J Natl Cancer Inst 2007, 99:715–726. Thompson IM, Ankerst DP, Chi C, et al.: Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006, 98:529–534. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23:1111–1130. Chuang RB, Hu WY, Chiu TY, Chen CY: Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage 2004, 28:115–122. Marrelli D, De Stefano A, de Manzoni G, et al.: Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 2005, 241:247–255. Meyer S, Gottschling S, Biran T, et al.: Assessing the risk of mortality in paediatric cancer patients admitted to the paediatric intensive care unit: a novel risk score? Eur J Pediatr 2005, 164:563–567. Regazzoni CJ, Irrazabal C, Luna CM, Poderoso JJ: Cancer patients with septic shock: mortality predictors and neutropenia. Support Care Cancer 2004, 12:833–839. Gail MH, Brinton LA, Byar DP, et al.: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879–1886. Surveillance, Epidemiology, and End Results (SEER) Program: SEER 17 Incidence and Mortality, 2000–2003, with Kaposi Sarcoma and Mesothelioma. Bethesda, MD: National Cancer Institute DCCPS, Surveillance Research Program, Cancer Statistics Branch, based on the November 2005 submission; 2006. Weinstein ND: What does it mean to understand a risk? Evaluating risk comprehension. J Natl Cancer Inst Monogr 1999, 25:15–20. Emmons KM, Wong M, Puleo E, et al.: Tailored computer-based cancer risk communication: correcting colorectal cancer risk perception. J Health Commun 2004, 9:127–141. Yamagishi K: When 12.86% mortality is more dangerous than 24.14%: implications for risk communication. Appl Cogn Psychol 1997, 11:495–506. Kirsch IS, Jungeblut A, Jenkins L, Kolstad A: Adult Literacy in America: A First Look at the Findings of the National Adult Literacy Survey, edn 3. Washington, DC: National Center for Education, US Department of Education; 2002. Gurmankin AD, Baron J, Armstrong K: The effect of numerical statements of risk on trust and comfort with hypothetical physician risk communication. Med Decis Making 2004, 24:265–271. Stone ER, Sieck WR, Bull BE, et al.: Foreground: background salience: Explaining the effects of graphical displays on risk avoidance. Organ Behav Hum Decis Process 2003, 90:19–36. Halpern DF, Blackman S, Salzman B: Using statistical risk to assess oral contraceptive safety. Appl Cogn Psychol 1989, 3:251–260. Haimes YY: Risk Modeling, Assessment, and Management. New York: John Wiley & Sons; 1998. US National Academy of Sciences: Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academies Press; 1983. Szymczak W, Szadkowska-Stanczyk I: Cancer risk assessment: present and future. Int J Occup Med Environ Health 2007, 18:207–223. Mirvish SS, Haorah J, Zhou L, et al.: Total N-nitroso compounds and their precursors in hot dogs and in the gastrointestinal tract and feces of rats and mice: possible etiologic agents for colon cancer. J Nutr 2002, 132(Suppl):3526S–3529S. Chao A, Thun MJ, Connell CJ, et al.: Meat consumption and risk of colorectal cancer. JAMA 2005, 293:172–182. Hertz-Picciotto I: Epidemiology and quantitative risk assessment: a bridge from science to policy. Am J Public Health 1995, 85:484–491. van Wijngaarden E, Hertz-Picciotto I: A simple approach to performing quantitative cancer risk assessment using published results from occupational epidemiology studies. Sci Total Environ 2004, 332:81–87. Reilly BM, Evans AT: Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006, 144:201–209. Laupacis A, Sekar N, Stiell JG: Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 1997, 277:488–494. Wasson JH, Sox HC, Neff RK, Goldman L: Clinical prediction rules. Applications and methodological standards. N Engl J Med 1985, 313:793–799. Kannel WB, McGee D, Gordon T: A general cardiovascular risk profile: the Framingham study. Am J Cardiol 1976, 38:46–51. Grundy SM, Balady GJ, Criqui MH, et al.: Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998, 97:1876–1887. Women’s Health Initiative Writing Group: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 2002, 288:321–325. Skinner CS, Strecher VJ, Hospers H: Physicians’ recommendations for mammography: do tailored messages make a difference? Am J Public Health 1994, 84:43–49. Your Disease Risk: the Source on Prevention. The Harvard Center for Cancer Prevention. Available at http://www.yourdiseaserisk.harvard.edu/hccpquiz.pl?lang=english&func=home&page=cancer_index. Accessed August 24, 2007. UCLA Internet Report 2001: Surveying the Digital Future. UCLA Center for Communication Policy. Available at http://www.ccp.ucla.edu. Accessed August 24, 2007. Eysenbach G, Powell J, Kuss O, Sa ER: Empirical studies assessing the quality of health information for consumers on the World Wide Web: a systematic review. JAMA 2002, 287:2691–2700. Breast Cancer Risk Assessment Tool. National Cancer Institute. Available at http://www.cancer.gov/bcrisktool. Accessed August 24, 2007. MacMahon B, Cole P, Brown JB, et al.: Oestrogen profiles of Asian and North American women. Lancet 1971, 2:900–902. Colditz GA, Stein CJ: Handbook of Cancer Risk Assessment and Prevention. Sudbury, MA: Jones and Bartlett Publishers; 2004. Poynter JN, Gruber SB, Higgins PD, et al.: Statins and the risk of colorectal cancer. N Engl J Med 2005, 352:2184–2192. Dale KM, Coleman CI, Henyan NH, et al.: Statins and cancer risk. JAMA 2006, 295:74–80. Freedman AN, Seminara D, Gail MH, et al.: Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst 2005, 97:715–723.